These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 29795311)
21. LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor. Sun J; Hu C; Zhu Y; Sun R; Fang Y; Fan Y; Xu F PLoS One; 2015; 10(8):e0134896. PubMed ID: 26244812 [TBL] [Abstract][Full Text] [Related]
22. Hypomethylation-associated ELF3 helps nasopharyngeal carcinoma to escape immune surveillance via MUC16-mediated glycolytic metabolic reprogramming. Liu Y; Zhou H; Yu Q; Wang Q Am J Physiol Cell Physiol; 2024 Oct; 327(4):C1125-C1142. PubMed ID: 39219440 [TBL] [Abstract][Full Text] [Related]
23. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway. Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380 [TBL] [Abstract][Full Text] [Related]
24. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells. Sung WW; Chu YC; Chen PR; Liao MH; Lee JW Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526 [TBL] [Abstract][Full Text] [Related]
25. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Tsai CL; Li HP; Lu YJ; Hsueh C; Liang Y; Chen CL; Tsao SW; Tse KP; Yu JS; Chang YS Cancer Res; 2006 Dec; 66(24):11668-76. PubMed ID: 17178861 [TBL] [Abstract][Full Text] [Related]
26. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517 [TBL] [Abstract][Full Text] [Related]
27. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma. Li Z; Duan Y; Cheng S; Chen Y; Hu Y; Zhang L; He J; Liao Q; Yang L; Sun LQ Oncotarget; 2015 Sep; 6(27):24291-303. PubMed ID: 26172457 [TBL] [Abstract][Full Text] [Related]
28. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Hino R; Uozaki H; Murakami N; Ushiku T; Shinozaki A; Ishikawa S; Morikawa T; Nakaya T; Sakatani T; Takada K; Fukayama M Cancer Res; 2009 Apr; 69(7):2766-74. PubMed ID: 19339266 [TBL] [Abstract][Full Text] [Related]
29. Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines. Lai HC; Hsiao JR; Chen CW; Wu SY; Lee CH; Su IJ; Takada K; Chang Y Virology; 2010 Sep; 405(2):464-73. PubMed ID: 20637487 [TBL] [Abstract][Full Text] [Related]
30. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation. Lui VW; Yau DM; Cheung CS; Wong SC; Chan AK; Zhou Q; Wong EY; Lau CP; Lam EK; Hui EP; Hong B; Hui CW; Chan AS; Ng PK; Ng YK; Lo KW; Tsang CM; Tsui SK; Tsao SW; Chan AT Oncogene; 2011 Mar; 30(13):1518-30. PubMed ID: 21119603 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743 [TBL] [Abstract][Full Text] [Related]
32. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559 [TBL] [Abstract][Full Text] [Related]
33. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma]. Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus latent membrane protein 1 (LMP1) regulates the aldehyde dehydrogenase (ALDH) positive cell population in nasopharyngeal carcinoma cell lines. Wu J; Su H; Li G; Huang Y Acta Virol; 2019; 63(3):322-327. PubMed ID: 31507199 [TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells. Port RJ; Pinheiro-Maia S; Hu C; Arrand JR; Wei W; Young LS; Dawson CW J Pathol; 2013 Nov; 231(3):367-77. PubMed ID: 23934731 [TBL] [Abstract][Full Text] [Related]
36. Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups. Wasil LR; Shair KHY J Virol; 2018 Sep; 92(18):. PubMed ID: 29950426 [TBL] [Abstract][Full Text] [Related]
37. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138 [TBL] [Abstract][Full Text] [Related]
38. Expression of miRNA-146a in nasopharyngeal carcinoma is upregulated by Epstein-Barr virus latent membrane protein 1. Zhao Y; Chen X; Jing M; Du H; Zeng Y Oncol Rep; 2012 Oct; 28(4):1237-42. PubMed ID: 22843060 [TBL] [Abstract][Full Text] [Related]
39. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway. Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659 [TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-encoded LMP1 increases miR-155 expression, which promotes radioresistance of nasopharyngeal carcinoma via suppressing UBQLN1. Yang F; Liu Q; Hu CM Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4507-15. PubMed ID: 26698246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]